July 9, 2024
Regulatory Focus — Industry, research push for clarity in clinical trial eligibility guidances
Industry and researchers welcomed a set of guidances from the US Food and Drug Administration (FDA) that seek to expand eligibility criteria in oncology clinical trials, but they pushed for clearer examples of how to apply the proposed flexibility, especially in early-stage trials. In April 2024, FDA issued a set of three draft guidance documents…
Read More